During clinical development of the licensed Japanese encephalitis chimeric virus vaccine ( JE-CV ) , the neutralization capacity of vaccine-induced antibodies was assessed against the vaccine virus and against well characterized wild-type ( wt ) viruses isolated between 1949-1991 .